| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroesophageal Reflux | 19 | 2015 | 405 | 2.860 |
Why?
|
| Esomeprazole | 9 | 2015 | 44 | 2.390 |
Why?
|
| Endoscopy, Gastrointestinal | 14 | 2012 | 233 | 2.170 |
Why?
|
| Proton Pump Inhibitors | 7 | 2015 | 326 | 1.640 |
Why?
|
| Endoscopy, Digestive System | 9 | 2018 | 155 | 1.640 |
Why?
|
| Esophagitis, Peptic | 7 | 2015 | 48 | 1.330 |
Why?
|
| Gastrointestinal Diseases | 9 | 2014 | 343 | 1.300 |
Why?
|
| Abdominal Pain | 10 | 2014 | 319 | 1.280 |
Why?
|
| Child, Preschool | 55 | 2018 | 15110 | 0.810 |
Why?
|
| Esophagoscopy | 9 | 2010 | 180 | 0.790 |
Why?
|
| Intestinal Mucosa | 5 | 2018 | 771 | 0.780 |
Why?
|
| Norwalk virus | 10 | 2015 | 115 | 0.780 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2012 | 19 | 0.750 |
Why?
|
| Starch | 2 | 2012 | 26 | 0.750 |
Why?
|
| Digestion | 2 | 2012 | 42 | 0.740 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 2 | 2012 | 39 | 0.730 |
Why?
|
| Gastrointestinal Hemorrhage | 6 | 2012 | 239 | 0.730 |
Why?
|
| Anti-Ulcer Agents | 5 | 2015 | 140 | 0.720 |
Why?
|
| Dietary Carbohydrates | 2 | 2012 | 106 | 0.710 |
Why?
|
| Child | 65 | 2018 | 26341 | 0.650 |
Why?
|
| Infant | 39 | 2015 | 13352 | 0.630 |
Why?
|
| Peptic Ulcer | 4 | 2015 | 151 | 0.590 |
Why?
|
| Adolescent | 47 | 2018 | 20987 | 0.560 |
Why?
|
| Disaccharidases | 1 | 2018 | 15 | 0.560 |
Why?
|
| Malabsorption Syndromes | 1 | 2018 | 27 | 0.550 |
Why?
|
| Esophagitis | 3 | 2008 | 46 | 0.550 |
Why?
|
| Pediatrics | 8 | 2015 | 1252 | 0.530 |
Why?
|
| Wound Healing | 4 | 2015 | 490 | 0.530 |
Why?
|
| Duodenum | 1 | 2018 | 111 | 0.520 |
Why?
|
| Dyspepsia | 1 | 2018 | 109 | 0.510 |
Why?
|
| Colonoscopy | 5 | 2015 | 243 | 0.490 |
Why?
|
| Midazolam | 3 | 2011 | 51 | 0.490 |
Why?
|
| Esophagus | 5 | 2011 | 258 | 0.480 |
Why?
|
| Double-Blind Method | 9 | 2015 | 1626 | 0.470 |
Why?
|
| Caliciviridae Infections | 7 | 2015 | 286 | 0.460 |
Why?
|
| Helicobacter Infections | 9 | 2018 | 1313 | 0.450 |
Why?
|
| Helicobacter pylori | 9 | 2018 | 1373 | 0.440 |
Why?
|
| Ketamine | 2 | 2011 | 206 | 0.430 |
Why?
|
| Humans | 96 | 2018 | 131163 | 0.430 |
Why?
|
| Colonic Polyps | 2 | 2012 | 82 | 0.420 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2009 | 327 | 0.400 |
Why?
|
| Male | 55 | 2018 | 64957 | 0.390 |
Why?
|
| Gastroenteritis | 6 | 2015 | 308 | 0.380 |
Why?
|
| Intestine, Large | 1 | 2012 | 12 | 0.380 |
Why?
|
| Platelet Activating Factor | 1 | 2012 | 22 | 0.370 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2012 | 28 | 0.370 |
Why?
|
| Adenomatous Polyps | 1 | 2012 | 15 | 0.370 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2012 | 56 | 0.360 |
Why?
|
| Female | 53 | 2018 | 70963 | 0.360 |
Why?
|
| Intestinal Perforation | 2 | 2012 | 51 | 0.360 |
Why?
|
| Glucocorticoids | 2 | 2012 | 348 | 0.340 |
Why?
|
| Constipation | 3 | 2013 | 131 | 0.330 |
Why?
|
| Antibodies, Viral | 7 | 2015 | 1176 | 0.320 |
Why?
|
| Immunoglobulin G | 6 | 2015 | 786 | 0.320 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 255 | 0.310 |
Why?
|
| Gastroenterology | 5 | 2014 | 233 | 0.310 |
Why?
|
| Cross-Sectional Studies | 12 | 2011 | 3829 | 0.310 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2012 | 259 | 0.290 |
Why?
|
| Gastroscopy | 4 | 2008 | 98 | 0.290 |
Why?
|
| Magnets | 3 | 2014 | 22 | 0.290 |
Why?
|
| Barrett Esophagus | 2 | 2011 | 357 | 0.290 |
Why?
|
| Hernia, Hiatal | 2 | 2008 | 57 | 0.290 |
Why?
|
| Fundoplication | 4 | 2014 | 82 | 0.280 |
Why?
|
| Databases as Topic | 2 | 2007 | 73 | 0.280 |
Why?
|
| Hypnotics and Sedatives | 2 | 2004 | 132 | 0.280 |
Why?
|
| Colonoscopes | 1 | 2008 | 9 | 0.280 |
Why?
|
| Cardia | 1 | 2008 | 25 | 0.270 |
Why?
|
| Esophageal Achalasia | 2 | 2014 | 50 | 0.270 |
Why?
|
| Colonic Diseases | 1 | 2008 | 38 | 0.260 |
Why?
|
| Opportunistic Infections | 1 | 2007 | 69 | 0.250 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 621 | 0.240 |
Why?
|
| Enema | 3 | 1995 | 45 | 0.240 |
Why?
|
| Prevalence | 10 | 2012 | 2701 | 0.240 |
Why?
|
| Treatment Outcome | 13 | 2015 | 12936 | 0.230 |
Why?
|
| Prospective Studies | 10 | 2018 | 6459 | 0.230 |
Why?
|
| Infant, Newborn | 12 | 2015 | 8635 | 0.230 |
Why?
|
| Autistic Disorder | 1 | 2009 | 398 | 0.230 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 573 | 0.220 |
Why?
|
| Risk Factors | 16 | 2014 | 11074 | 0.220 |
Why?
|
| Diarrhea | 4 | 2015 | 301 | 0.220 |
Why?
|
| Cytomegalovirus Infections | 1 | 2007 | 223 | 0.220 |
Why?
|
| Biopsy | 6 | 2011 | 1239 | 0.220 |
Why?
|
| Gastric Mucosa | 1 | 2008 | 494 | 0.210 |
Why?
|
| Therapeutic Irrigation | 2 | 1995 | 45 | 0.210 |
Why?
|
| Age Factors | 10 | 2014 | 2825 | 0.210 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 229 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 787 | 0.210 |
Why?
|
| Retrospective Studies | 14 | 2018 | 17753 | 0.200 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2003 | 15 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1996 | 218 | 0.190 |
Why?
|
| Esophageal Diseases | 3 | 1997 | 38 | 0.180 |
Why?
|
| Colitis, Ulcerative | 2 | 2015 | 211 | 0.180 |
Why?
|
| Caustics | 1 | 2001 | 5 | 0.180 |
Why?
|
| Foreign Bodies | 2 | 2013 | 98 | 0.170 |
Why?
|
| Headache | 2 | 2015 | 107 | 0.170 |
Why?
|
| Esophageal Stenosis | 1 | 2001 | 46 | 0.170 |
Why?
|
| Feces | 7 | 2015 | 721 | 0.170 |
Why?
|
| Incidence | 5 | 2013 | 3360 | 0.160 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2000 | 38 | 0.160 |
Why?
|
| Confidence Intervals | 3 | 2011 | 272 | 0.160 |
Why?
|
| Biopsy, Needle | 1 | 2000 | 204 | 0.160 |
Why?
|
| Meperidine | 2 | 2004 | 5 | 0.150 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2000 | 77 | 0.150 |
Why?
|
| Societies, Medical | 5 | 2014 | 798 | 0.140 |
Why?
|
| Oxygen | 2 | 2011 | 548 | 0.140 |
Why?
|
| Colitis | 2 | 2000 | 166 | 0.140 |
Why?
|
| Rotavirus Infections | 4 | 1998 | 281 | 0.140 |
Why?
|
| Immunoglobulin A | 4 | 2015 | 201 | 0.140 |
Why?
|
| Logistic Models | 5 | 2014 | 1797 | 0.130 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 129 | 0.130 |
Why?
|
| Crohn Disease | 1 | 2000 | 292 | 0.130 |
Why?
|
| Pyloric Stenosis | 1 | 1996 | 8 | 0.130 |
Why?
|
| Manometry | 1 | 1997 | 96 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 563 | 0.120 |
Why?
|
| United States | 9 | 2018 | 12072 | 0.120 |
Why?
|
| Mycobacterium avium Complex | 1 | 1996 | 20 | 0.120 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1996 | 24 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2000 | 385 | 0.120 |
Why?
|
| Liver | 2 | 2000 | 1796 | 0.120 |
Why?
|
| Virus Shedding | 3 | 2013 | 76 | 0.110 |
Why?
|
| Barium Sulfate | 1 | 1995 | 13 | 0.110 |
Why?
|
| Deglutition | 2 | 2013 | 58 | 0.110 |
Why?
|
| Catheterization | 1 | 1996 | 226 | 0.110 |
Why?
|
| Ileal Diseases | 1 | 1995 | 26 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 2085 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2015 | 26 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2011 | 4066 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2010 | 1246 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2014 | 158 | 0.100 |
Why?
|
| Breath Tests | 4 | 2009 | 182 | 0.100 |
Why?
|
| Intestinal Polyps | 2 | 2011 | 28 | 0.100 |
Why?
|
| Documentation | 1 | 2015 | 121 | 0.100 |
Why?
|
| Intestinal Obstruction | 1 | 1995 | 86 | 0.100 |
Why?
|
| Fecal Impaction | 1 | 1994 | 9 | 0.100 |
Why?
|
| Adrenal Insufficiency | 1 | 2014 | 28 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2010 | 2904 | 0.100 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 1 | 2013 | 1 | 0.100 |
Why?
|
| Household Articles | 1 | 2013 | 2 | 0.100 |
Why?
|
| Laxatives | 1 | 2013 | 9 | 0.100 |
Why?
|
| Cathartics | 1 | 1993 | 31 | 0.100 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 67 | 0.100 |
Why?
|
| Defecation | 1 | 2013 | 33 | 0.100 |
Why?
|
| Play and Playthings | 1 | 2013 | 14 | 0.100 |
Why?
|
| Benzofurans | 1 | 2013 | 33 | 0.100 |
Why?
|
| Diazepam | 1 | 1993 | 20 | 0.100 |
Why?
|
| Child Welfare | 1 | 2014 | 71 | 0.100 |
Why?
|
| Antibody Formation | 2 | 2012 | 227 | 0.100 |
Why?
|
| Anesthesia | 1 | 1995 | 208 | 0.100 |
Why?
|
| Intestines | 2 | 2012 | 587 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 240 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2007 | 365 | 0.090 |
Why?
|
| Age of Onset | 2 | 2012 | 592 | 0.090 |
Why?
|
| Celecoxib | 1 | 2012 | 34 | 0.090 |
Why?
|
| Pentoxifylline | 1 | 2012 | 20 | 0.090 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2012 | 42 | 0.090 |
Why?
|
| Colon | 1 | 2015 | 373 | 0.090 |
Why?
|
| Hemagglutination, Viral | 1 | 2011 | 9 | 0.090 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1992 | 44 | 0.090 |
Why?
|
| Intussusception | 1 | 2012 | 54 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2014 | 298 | 0.090 |
Why?
|
| Rectal Diseases | 1 | 2011 | 19 | 0.090 |
Why?
|
| Arab World | 1 | 2011 | 1 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2012 | 131 | 0.090 |
Why?
|
| Adult | 17 | 2015 | 31282 | 0.090 |
Why?
|
| DiGeorge Syndrome | 1 | 1992 | 83 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 301 | 0.090 |
Why?
|
| Fluoroimmunoassay | 1 | 2011 | 5 | 0.090 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1992 | 107 | 0.090 |
Why?
|
| Recurrence | 4 | 2010 | 1489 | 0.090 |
Why?
|
| Time Factors | 5 | 2014 | 6196 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 211 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 525 | 0.080 |
Why?
|
| Antigens, Viral | 1 | 2012 | 395 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 1882 | 0.080 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 47 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2012 | 296 | 0.080 |
Why?
|
| Young Adult | 7 | 2015 | 10103 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2012 | 349 | 0.080 |
Why?
|
| Microbiota | 1 | 2015 | 438 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 64 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2010 | 139 | 0.070 |
Why?
|
| Minnesota | 1 | 2009 | 178 | 0.070 |
Why?
|
| Trachea | 1 | 2011 | 209 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1993 | 482 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2012 | 1295 | 0.070 |
Why?
|
| Intestinal Absorption | 1 | 2009 | 170 | 0.070 |
Why?
|
| Illinois | 1 | 2008 | 17 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2010 | 234 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 38 | 0.070 |
Why?
|
| Registries | 1 | 2015 | 1634 | 0.070 |
Why?
|
| Saliva | 2 | 2015 | 125 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 981 | 0.070 |
Why?
|
| Eosinophils | 1 | 2009 | 122 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2014 | 3061 | 0.070 |
Why?
|
| Sex Factors | 2 | 2009 | 1356 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 1992 | 477 | 0.070 |
Why?
|
| Thyrotoxicosis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2014 | 3147 | 0.060 |
Why?
|
| Endoscopes, Gastrointestinal | 2 | 2004 | 8 | 0.060 |
Why?
|
| Contraceptives, Oral | 1 | 2007 | 37 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 294 | 0.060 |
Why?
|
| North America | 2 | 2005 | 255 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2009 | 291 | 0.060 |
Why?
|
| Vomiting | 2 | 1999 | 103 | 0.060 |
Why?
|
| Infant, Premature | 1 | 2012 | 872 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2323 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2008 | 1378 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 236 | 0.060 |
Why?
|
| Thyroidectomy | 1 | 2007 | 97 | 0.060 |
Why?
|
| Research | 3 | 2004 | 264 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2007 | 555 | 0.060 |
Why?
|
| Colonography, Computed Tomographic | 2 | 2004 | 5 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2007 | 263 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 781 | 0.060 |
Why?
|
| Algorithms | 1 | 2012 | 1680 | 0.060 |
Why?
|
| Hypoxia | 1 | 2007 | 247 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2007 | 3359 | 0.050 |
Why?
|
| Monitoring, Physiologic | 2 | 2000 | 376 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1618 | 0.050 |
Why?
|
| Benchmarking | 1 | 2005 | 137 | 0.050 |
Why?
|
| Comorbidity | 1 | 2009 | 1595 | 0.050 |
Why?
|
| Life Style | 1 | 2007 | 456 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 5196 | 0.050 |
Why?
|
| Endoscopy | 2 | 2004 | 270 | 0.050 |
Why?
|
| Antibodies, Bacterial | 2 | 2002 | 406 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 889 | 0.050 |
Why?
|
| Gastritis | 2 | 2003 | 374 | 0.050 |
Why?
|
| Gastroplasty | 1 | 2001 | 18 | 0.040 |
Why?
|
| Asthma | 1 | 2010 | 922 | 0.040 |
Why?
|
| Administration, Oral | 4 | 2013 | 711 | 0.040 |
Why?
|
| Prognosis | 1 | 2011 | 4886 | 0.040 |
Why?
|
| Burns, Chemical | 1 | 2001 | 31 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 2001 | 83 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2001 | 81 | 0.040 |
Why?
|
| Equipment Safety | 1 | 2000 | 34 | 0.040 |
Why?
|
| Needles | 1 | 2000 | 48 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2000 | 65 | 0.040 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2000 | 49 | 0.040 |
Why?
|
| Megacolon | 1 | 2000 | 3 | 0.040 |
Why?
|
| Hematocrit | 1 | 2000 | 104 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2000 | 80 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 93 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1121 | 0.040 |
Why?
|
| Hirschsprung Disease | 1 | 2000 | 39 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2000 | 153 | 0.040 |
Why?
|
| Peritonitis | 1 | 2000 | 75 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2000 | 107 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2003 | 564 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2000 | 286 | 0.040 |
Why?
|
| Rotavirus | 2 | 1992 | 367 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2000 | 331 | 0.040 |
Why?
|
| Sialic Acids | 1 | 1999 | 17 | 0.040 |
Why?
|
| Virion | 1 | 1999 | 115 | 0.040 |
Why?
|
| Lactose | 1 | 1999 | 55 | 0.040 |
Why?
|
| Fasting | 1 | 2000 | 303 | 0.040 |
Why?
|
| Hospitals, Pediatric | 2 | 2014 | 808 | 0.040 |
Why?
|
| Viral Vaccines | 2 | 2000 | 324 | 0.040 |
Why?
|
| Lactoferrin | 1 | 1999 | 76 | 0.030 |
Why?
|
| Child Nutritional Physiological Phenomena | 3 | 2004 | 157 | 0.030 |
Why?
|
| Serologic Tests | 2 | 2011 | 122 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 1173 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2000 | 487 | 0.030 |
Why?
|
| Gastric Outlet Obstruction | 1 | 1996 | 14 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 393 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2014 | 1211 | 0.030 |
Why?
|
| Hypertrophy | 1 | 1996 | 100 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2000 | 943 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1996 | 94 | 0.030 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1996 | 68 | 0.030 |
Why?
|
| Prednisone | 1 | 1996 | 235 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1996 | 351 | 0.030 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2015 | 52 | 0.030 |
Why?
|
| Obesity | 1 | 2007 | 2426 | 0.030 |
Why?
|
| Blastocystis hominis | 1 | 1994 | 1 | 0.030 |
Why?
|
| Blastocystis Infections | 1 | 1994 | 5 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 1995 | 140 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2000 | 546 | 0.030 |
Why?
|
| Virus Replication | 2 | 1999 | 608 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 42 | 0.030 |
Why?
|
| Urea | 2 | 2009 | 220 | 0.030 |
Why?
|
| Solutions | 1 | 1993 | 50 | 0.030 |
Why?
|
| Infliximab | 1 | 2014 | 61 | 0.030 |
Why?
|
| Bicarbonates | 1 | 1994 | 98 | 0.030 |
Why?
|
| Chlorides | 1 | 1994 | 97 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 225 | 0.020 |
Why?
|
| Health Transition | 1 | 2013 | 10 | 0.020 |
Why?
|
| Consumer Product Safety | 1 | 2013 | 29 | 0.020 |
Why?
|
| Tablets | 1 | 2013 | 37 | 0.020 |
Why?
|
| Granuloma | 1 | 1994 | 59 | 0.020 |
Why?
|
| Sutures | 1 | 1994 | 63 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 354 | 0.020 |
Why?
|
| Colectomy | 1 | 2014 | 89 | 0.020 |
Why?
|
| Placebos | 1 | 2013 | 223 | 0.020 |
Why?
|
| Acute Disease | 2 | 2010 | 1153 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 670 | 0.020 |
Why?
|
| Fecal Incontinence | 1 | 2013 | 71 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 2013 | 65 | 0.020 |
Why?
|
| Neodymium | 1 | 2012 | 6 | 0.020 |
Why?
|
| Potassium | 1 | 1994 | 263 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 304 | 0.020 |
Why?
|
| Patients | 1 | 1993 | 122 | 0.020 |
Why?
|
| Sodium | 1 | 1994 | 280 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2012 | 33 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 1992 | 31 | 0.020 |
Why?
|
| Immunoassay | 1 | 2012 | 126 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 235 | 0.020 |
Why?
|
| Oximetry | 1 | 1993 | 176 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 743 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 2 | 2003 | 158 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 905 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2011 | 112 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2000 | 1147 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2013 | 166 | 0.020 |
Why?
|
| Child Behavior | 1 | 2013 | 232 | 0.020 |
Why?
|
| Aging | 1 | 1998 | 1242 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2014 | 5063 | 0.020 |
Why?
|
| Pain | 1 | 1994 | 450 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2013 | 396 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2007 | 915 | 0.020 |
Why?
|
| Middle Aged | 5 | 2013 | 28601 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 105 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 377 | 0.020 |
Why?
|
| Texas | 2 | 2014 | 3686 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2010 | 143 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 2010 | 86 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2009 | 39 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 54 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2595 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 52 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2009 | 227 | 0.020 |
Why?
|
| Rabbits | 3 | 1998 | 575 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2014 | 541 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 599 | 0.020 |
Why?
|
| Electrocardiography | 1 | 1993 | 970 | 0.020 |
Why?
|
| Overweight | 1 | 2010 | 387 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 230 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 676 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2009 | 410 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2008 | 497 | 0.020 |
Why?
|
| Urease | 1 | 2006 | 73 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 371 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 463 | 0.010 |
Why?
|
| Education | 1 | 2006 | 112 | 0.010 |
Why?
|
| Metaplasia | 1 | 2006 | 215 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1224 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 928 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 2730 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 237 | 0.010 |
Why?
|
| Endosonography | 1 | 2004 | 75 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 306 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2010 | 1089 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 437 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 318 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 422 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 716 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 1489 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2002 | 81 | 0.010 |
Why?
|
| Psychometrics | 1 | 2005 | 678 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 953 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 1717 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 2000 | 95 | 0.010 |
Why?
|
| Colostrum | 1 | 1999 | 56 | 0.010 |
Why?
|
| Vaccines, Synthetic | 1 | 2000 | 325 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 281 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2304 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 322 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 422 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 2200 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 501 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 274 | 0.010 |
Why?
|
| Animals | 5 | 1999 | 33912 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2002 | 1240 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 239 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 1319 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 3711 | 0.010 |
Why?
|
| Gastric Fundus | 1 | 1994 | 9 | 0.010 |
Why?
|
| Rectum | 1 | 1994 | 102 | 0.010 |
Why?
|
| Metronidazole | 1 | 1994 | 161 | 0.010 |
Why?
|
| Polyps | 1 | 1994 | 38 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1991 | 43 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1991 | 226 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1991 | 210 | 0.000 |
Why?
|
| Kinetics | 1 | 1991 | 1088 | 0.000 |
Why?
|
| Mice | 1 | 1998 | 18301 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1991 | 4697 | 0.000 |
Why?
|
| Aged | 1 | 1999 | 21025 | 0.000 |
Why?
|